Last $163.78 USD
Change Today +1.04 / 0.64%
Volume 1.2M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:30 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

Pension Plan for alexion pharmaceuticals inc (ALXN)

Shares for Stock Options
-- Million
Common Shares for Exercise
For the fiscal year 2013 in U.S. Dollars
Projected Benefit Obligation5.41
Accumulative Benefit Obligation0.50
Total Pension Assets23.33
Def. Benefit Service Cost5.41
Def. Benefit Plan Interest Cost0.50
Def. Benefit Plan Return On Assets-0.63
Def. Benefit Plan Other Cost-1.10
Def. Benefit Plan Total Cost4.18
Def. Contribution Plan Cost6.36
Total Pension Expense10.54
Exp. Ret. on Pension Assets--
Discount Rate on Obligation--
Assumed Comp. Growth Rate--
Other Post-Retire Benefits Exp.--
Other Benefits Obligation--

Stock Options for alexion pharmaceuticals inc (ALXN)

Outstanding at Beginning of Year9.56
Issued During the Year2.00
Exercised During the Year2.48
Canceled During the Year0.46
Outstanding at the End of Year8.62
W/Avg. Exercise Price of Options Granted97.30
W/Avg. Exercise Price of Options Outstanding50.69
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $163.78 USD +1.04

ALXN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Intrexon Corp $23.19 USD +0.48
MorphoSys AG €72.51 EUR +0.262
Regeneron Pharmaceuticals Inc $304.51 USD +2.35
United Therapeutics Corp $98.21 USD +7.36
Vertex Pharmaceuticals Inc $95.56 USD 0.00
View Industry Companies
 

Industry Analysis

ALXN

Industry Average

Valuation ALXN Industry Range
Price/Earnings 81.9x
Price/Sales 16.8x
Price/Book 11.2x
Price/Cash Flow 80.3x
TEV/Sales 15.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.